Home › Funds › Siren, L.L.C. › CYTK
Siren, L.L.C. position in CYTK
Cytokinetics, Incorporated · Health Care
Siren, L.L.C. reported holding 708,952 shares of CYTK (Cytokinetics, Incorporated) in its Q3 2026 13F filing — a position valued at US$46.7M, representing 1.11% of its reported portfolio and ranking #27 among its reported holdings. Siren, L.L.C. has disclosed CYTK holdings in 5 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR
How Siren, L.L.C.'s CYTK position evolved
Siren, L.L.C. first disclosed a stake in CYTK in Q3 2024 at 525,971 shares (US$27.8M). The position peaked in Q2 2026 at 758,952 shares, worth US$64.7M. Across 5 filings, Siren, L.L.C. increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 708,952 shares valued at US$46.7M — a reduction of -50,000 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 525.97K | $27.77M | New |
| Q4 2024 | 402.32K | $18.93M | Reduce |
| Q1 2026 | 613.95K | $40.47M | New |
| Q2 2026 | 758.95K | $64.66M | Add |
| Q3 2026 | 708.95K | $46.73M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CYTK and 13F data
CYTK (Cytokinetics, Incorporated) is a Health Care company. 51 other funds we track also report a position in CYTK — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$1.59B), Avoro Capital Advisors LLC (US$425.9M), RTW INVESTMENTS, LP (US$243.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CYTK
- T. Rowe Price Investment Management, Inc. 18.72M sh · $1.59B · Q2 2026
- Avoro Capital Advisors LLC 5.00M sh · $425.95M · Q2 2026
- RTW INVESTMENTS, LP 2.86M sh · $243.81M · Q2 2026
- Polar Capital Holdings Plc 2.25M sh · $191.99M · Q2 2026
- Integral Health Asset Management, LLC 1.60M sh · $136.30M · Q2 2026
- ARMISTICE CAPITAL, LLC 1.20M sh · $102.34M · Q2 2026
- Frazier Life Sciences Management, L.P. 1.16M sh · $98.81M · Q2 2026
- Royalty Pharma Sub-Manager, LLC 980.39K sh · $83.52M · Q2 2026
- GW&K Investment Management, LLC 916.11K sh · $78.04M · Q2 2026
- Melqart Asset Management (UK) Ltd 767.52K sh · $65.39M · Q2 2026
- Foresite Capital Management IV, LLC 714.70K sh · $60.88M · Q2 2026
- Deep Track Capital, LP 700.00K sh · $59.63M · Q2 2026
More on Siren, L.L.C.
FAQ
How long has Siren, L.L.C. held CYTK?
Siren, L.L.C. has disclosed CYTK holdings in 5 of the last 9 reported quarters, going back to Q3 2024.
What is Siren, L.L.C.'s current position in CYTK?
As of Q3 2026, Siren, L.L.C. holds 708.95K shares of CYTK (Cytokinetics, Incorporated), valued at $46.73M, representing 1.11% of its reported portfolio and ranking #27.
Has Siren, L.L.C. been buying or selling CYTK?
In the latest 13F filing (Q3 2026), Siren, L.L.C. reduced its position in CYTK. The position peaked in Q2 2026 at 758.95K shares.
Which other funds hold CYTK?
Other major institutional holders of CYTK include T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, RTW INVESTMENTS, LP, among 51 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.